Multiple Myeloma Treatment Strategies with Novel Agents in 2011: A European Perspective

The arrival of the novel agents thalidomide, bortezomib, and lenalidomide has significantly changed our approach to the management of multiple myeloma and, importantly, patient outcomes have improved. These agents have been investigated intensively in different treatment settings, providing us with...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ludwig, Heinz, Beksac, Meral, Bladé, Joan, Cavenagh, Jamie, Cavo, Michele, Delforge, Michel, Dimopoulos, Meletios, Drach, Johannes, Einsele, Hermann, Facon, Thierry, Goldschmidt, Hartmut, Harousseau, Jean-Luc, Hess, Urs, Kropff, Martin, Leal da Costa, Fernando, Louw, Vernon, Magen-Nativ, Hila, Mendeleeva, Larisa, Nahi, Hareth, Plesner, Torben, San-Miguel, Jesús, Sonneveld, Pieter, Udvardy, Miklos, Sondergeld, Pia, Palumbo, Antonio
Format: Artigo
Langue:Inglês
Publié: AlphaMed Press 2011
Sujets:
Academia-Pharma Intersect
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3228121/
https://ncbi.nlm.nih.gov/pubmed/21441574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0386
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires